Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data

Abstract

Background Despite extensive research into acute kidney injury (AKI) in adults, research into the epidemiology, associated risk factors, treatment, and mortality of AKI in pediatric COVID-19 patients is understudied. Advancing understanding of this disease is crucial to further developing treatment and preventative care strategies to reduce morbidity and mortality. Methods This is a retrospective analysis of 2,546 COVID-19 pediatric patients (age ≤ 21 years) who were admitted the ICU in North America. Analysis of the Virtual Pediatric Systems (VPS) COVID-19 database was conducted between January 1, 2020, and June 30, 2021. Results Out of a total of 2,546 COVID positive pediatric patients, 10.8% (n = 274) were diagnosed with AKI. Significantly higher continuous and categorical outcomes in the AKI subset compared to the non-AKI cohort included: length of stay at the hospital (LOS) [9.04 (5.11–16.66) vs. 5.09 (2.58–9.94) days], Pediatric Index of Mortality (PIM) 2 probability of death [1.20 (0.86–3.83) vs. 0.96 (0.79–1.72)], PIM 3 probability of death [0.98 (0.72–2.93) vs. 0.78 (0.69–1.26)], mortality [crude OR (95% CI): 5.01 (2.89–8.70)], airway and respiratory support [1.63 (1.27–2.10)], cardio-respiratory support [3.57 (1.55–8.23)], kidney support [12.52 (5.30–29.58)], and vascular access [4.84 (3.70–6.32)]. Conclusions This is one of the first large scale studies to analyze AKI among pediatric COVID-19 patients admitted to the ICU in North America. Although the course of the COVID-19 virus appears milder in the pediatric population, renal complications may result, increasing the risk of disease complication and mortality.

Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study

“…While acute kidney injury was one of the most frequently noted AEs in the preliminary results of the CARAVAN study with 11% of patients developing renal impairment, this finding could not be replicated by either this study or prior investigations in children (Table 4 ) [ 14 ]. As the CARAVAN study enrolled a higher proportion of patients with critical COVID-19, this finding may be a consequence of severe illness rather than drug-induced renal impairment [ 31 ]. Furthermore, a meta-analysis of adult RCTs similarly failed to demonstrate an increased incidence of acute kidney injury in patients receiving RDV, suggesting that renal damage is more likely a function of SARS-CoV-2 infection itself [ 32 ].…”

A retrospective analysis of acute kidney injury in children with post-COVID-19 multisystem inflammatory syndrome: insights into promising outcomes

“…In the same studies associated with systolic dysfunction, the need for inotropes and lower levels of albumin and bicarbonates were monitored. Therefore, these data suggest a double component in the pathogenesis of AKI in MIS-C due to both an inflammatory pathway and prerenal injury [ 40 – 42 ].…”

Pediatric intensive care unit admissions network—rationale, framework and method of operation of a nationwide collaborative pediatric intensive care research network in Germany

“…In Germany, subgroups of critically ill children are reported to the German TraumaRegister DGU ® , German Resuscitation registry and the German Neonatal Network, and the German Burn Registry. Results retrieved from these registries have advanced the field and some have permanently impacted patient care (6)(7)(8)(9)(10)(11)(12)(13)(14).…”